These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 38026955)

  • 1. Strategies targeting endoplasmic reticulum stress to improve Parkinson's disease.
    Wang D; Qu S; Zhang Z; Tan L; Chen X; Zhong HJ; Chong CM
    Front Pharmacol; 2023; 14():1288894. PubMed ID: 38026955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Cross-Links of Endoplasmic Reticulum Stress, Autophagy, and Neurodegeneration in Parkinson's Disease.
    Ren H; Zhai W; Lu X; Wang G
    Front Aging Neurosci; 2021; 13():691881. PubMed ID: 34168552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of the unfolded protein response (UPR) as therapy for Parkinson's disease.
    Martinez A; Lopez N; Gonzalez C; Hetz C
    Biol Cell; 2019 Jun; 111(6):161-168. PubMed ID: 30860281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ER stress and Parkinson's disease: Pathological inputs that converge into the secretory pathway.
    Mercado G; Castillo V; Soto P; Sidhu A
    Brain Res; 2016 Oct; 1648(Pt B):626-632. PubMed ID: 27103567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoplasmic Reticulum Stress Regulators: New Drug Targets for Parkinson's Disease.
    Kovaleva V; Saarma M
    J Parkinsons Dis; 2021; 11(s2):S219-S228. PubMed ID: 34180421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ER Stress Induced by Tunicamycin Triggers α-Synuclein Oligomerization, Dopaminergic Neurons Death and Locomotor Impairment: a New Model of Parkinson's Disease.
    Cóppola-Segovia V; Cavarsan C; Maia FG; Ferraz AC; Nakao LS; Lima MM; Zanata SM
    Mol Neurobiol; 2017 Oct; 54(8):5798-5806. PubMed ID: 27660269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GRP78/BIP/HSPA5 as a Therapeutic Target in Models of Parkinson's Disease: A Mini Review.
    Enogieru AB; Omoruyi SI; Hiss DC; Ekpo OE
    Adv Pharmacol Sci; 2019; 2019():2706783. PubMed ID: 30949202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting calcium homeostasis and impaired inter-organelle crosstalk as a potential therapeutic approach in Parkinson's disease.
    Kaur S; Sehrawat A; Mastana SS; Kandimalla R; Sharma PK; Bhatti GK; Bhatti JS
    Life Sci; 2023 Oct; 330():121995. PubMed ID: 37541578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting PERK signaling with the small molecule GSK2606414 prevents neurodegeneration in a model of Parkinson's disease.
    Mercado G; Castillo V; Soto P; López N; Axten JM; Sardi SP; Hoozemans JJM; Hetz C
    Neurobiol Dis; 2018 Apr; 112():136-148. PubMed ID: 29355603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of endoplasmic reticulum stress is involved in the neuroprotective effects of candesartan cilexitil in the rotenone rat model of Parkinson's disease.
    Wu L; Tian YY; Shi JP; Xie W; Shi JQ; Lu J; Zhang YD
    Neurosci Lett; 2013 Aug; 548():50-5. PubMed ID: 23774475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay of α-Synuclein Oligomers and Endoplasmic Reticulum Stress in Parkinson'S Disease: Insights into Cellular Dysfunctions.
    Zeng H; Liu Y; Liu X; Li J; Lu L; Xue C; Wu X; Zhang X; Zheng Z; Lu G
    Inflammation; 2024 Oct; ():. PubMed ID: 39382817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotoxin-induced ER stress in mouse dopaminergic neurons involves downregulation of TRPC1 and inhibition of AKT/mTOR signaling.
    Selvaraj S; Sun Y; Watt JA; Wang S; Lei S; Birnbaumer L; Singh BB
    J Clin Invest; 2012 Apr; 122(4):1354-67. PubMed ID: 22446186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ca
    Xu J; Minobe E; Kameyama M
    Front Cell Neurosci; 2022; 16():867385. PubMed ID: 35496903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trib3 Is Elevated in Parkinson's Disease and Mediates Death in Parkinson's Disease Models.
    Aimé P; Sun X; Zareen N; Rao A; Berman Z; Volpicelli-Daley L; Bernd P; Crary JF; Levy OA; Greene LA
    J Neurosci; 2015 Jul; 35(30):10731-49. PubMed ID: 26224857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An ERcentric view of Parkinson's disease.
    Mercado G; Valdés P; Hetz C
    Trends Mol Med; 2013 Mar; 19(3):165-75. PubMed ID: 23352769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ageing enhances alpha-synuclein, ubiquitin and endoplasmic reticular stress protein expression in the nigral neurons of Asian Indians.
    Alladi PA; Mahadevan A; Vijayalakshmi K; Muthane U; Shankar SK; Raju TR
    Neurochem Int; 2010 Nov; 57(5):530-9. PubMed ID: 20615443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α-Synuclein-mediated inhibition of ATF6 processing into COPII vesicles disrupts UPR signaling in Parkinson's disease.
    Credle JJ; Forcelli PA; Delannoy M; Oaks AW; Permaul E; Berry DL; Duka V; Wills J; Sidhu A
    Neurobiol Dis; 2015 Apr; 76():112-125. PubMed ID: 25725420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondria, calcium, and endoplasmic reticulum stress in Parkinson's disease.
    Calì T; Ottolini D; Brini M
    Biofactors; 2011; 37(3):228-40. PubMed ID: 21674642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Endoplasmic Reticulum Stress/Unfolded Protein Response and Their Contributions to Parkinson's Disease Physiopathology.
    Costa CAD; Manaa WE; Duplan E; Checler F
    Cells; 2020 Nov; 9(11):. PubMed ID: 33212954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salidroside Protects Against 6-Hydroxydopamine-Induced Cytotoxicity by Attenuating ER Stress.
    Tao K; Wang B; Feng D; Zhang W; Lu F; Lai J; Huang L; Nie T; Yang Q
    Neurosci Bull; 2016 Feb; 32(1):61-9. PubMed ID: 26762342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.